Citation: P. Von Hoegen, Synthetic biomimetic supra molecular Biovector (TM) (SMBV (TM)) particles for nasal vaccine delivery, ADV DRUG DE, 51(1-3), 2001, pp. 113-125
Authors:
Schirrmacher, V
Forg, P
Dalemans, W
Chlichlia, K
Zeng, Y
Fournier, P
von Hoegen, P
Citation: V. Schirrmacher et al., Infra-pinna anti-tumor vaccination with self-replicating infectious RNA orwith DNA encoding a model tumor antigen and a cytokine, GENE THER, 7(13), 2000, pp. 1137-1147
Authors:
Jones, GJ
von Hoegen, P
Weber, J
Rees, AD
Citation: Gj. Jones et al., Immunization with human immunodeficiency virus type 1 rgp120(W61D) in QS21/MPL adjuvant primes T cell proliferation and C-C chemokine production to multiple epitopes within variable and conserved domains of gp120(W61D), J INFEC DIS, 179(3), 1999, pp. 558-566